El-Nono Ibrahiem H, Telha Khaled A, Al-Alimy Gamil M, Ghilan Abdulilah M, Abu Asba Nagieb W, Al-Zkri Abdo M, Al-Adimi Abdulilah M, Al-Ba'adani Tawfiq H
Urology and Nephrology Center, Al-Thawra Hospital, Sana'a University, Sana'a, Yemen.
Ann Transplant. 2015 Feb 16;20:92-6. doi: 10.12659/AOT.891362.
Background Renal replacement therapy was first introduced in Yemen in 1978 in the form of hemodialysis. Twenty years later, the first renal transplantation was performed. Kidney transplantations were started in socially and financially challenging circumstances in Yemen in 1998. A structured program was established and has been functioning regularly since 2005. A pediatric transplantation program was started in 2011. Material and Methods This was a prospective study of 181 transplants performed at the Urology and Nephrology Center between May 1998 and 2012. All transplants were from living related donors. The immunosuppressive protocol consisted initially of double therapy with steroid and mycophenolate mofetil (MMF). Subsequently, triple therapy with addition of a calcineurin inhibitor was introduced. Primary graft function was achieved in 176 (97.2%) recipients. Results Cold ischemia time was 48-68 min. Episodes of acute rejection in 12 patients were treated with high-dose steroids. Anti-thymocyte globulin (ATG) was used in cases of vascular or steroid-resistant rejection in 2 patients. The post-transplant complications, either surgical or medical, were comparable to those recorded in the literature. Conclusions Renal transplantation is a good achievement in our country. The patients and graft survival rates are comparable to other reports.
背景 1978 年,肾脏替代疗法以血液透析的形式首次引入也门。二十年后,首例肾移植手术得以开展。1998 年,也门在社会和经济面临挑战的情况下启动了肾移植项目。2005 年建立了一个结构化项目并一直正常运作。2011 年启动了儿科移植项目。
材料与方法 这是一项对 1998 年 5 月至 2012 年期间在泌尿外科和肾病中心进行的 181 例移植手术的前瞻性研究。所有移植均来自活体亲属供体。免疫抑制方案最初包括类固醇和霉酚酸酯(MMF)的双联疗法。随后,引入了添加钙调神经磷酸酶抑制剂的三联疗法。176 名(97.2%)受者实现了原发性移植肾功能。
结果 冷缺血时间为 48 - 68 分钟。12 例急性排斥反应发作的患者接受了大剂量类固醇治疗。2 例血管性或类固醇抵抗性排斥反应的患者使用了抗胸腺细胞球蛋白(ATG)。移植后的手术或医疗并发症与文献报道的相当。
结论 肾移植在我国是一项了不起的成就。患者和移植物存活率与其他报告相当。